ADC Therapeutics
ADCT
ADCT
59 hedge funds and large institutions have $90.9M invested in ADC Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 60 → 59 (-1)
39% less capital invested
Capital invested by funds: $149M → $90.9M (-$58.2M)
65% less call options, than puts
Call options by funds: $8K | Put options by funds: $23K
Holders
59
Holding in Top 10
2
Calls
$8K
Puts
$23K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$5.45M | |
| 3 | +$4.21M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$3.21M |
| 5 |
PA
Perceptive Advisors
New York
|
+$2.92M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$9M | |
| 3 | -$3.14M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.71M |
| 5 |
Walleye Capital
New York
|
-$1.97M |